Biogen wins accelerated FDA approval for treatment for rare form of ALS
The U.S. Food and Drug Administration said Tuesday it has granted accelerated approval to Biogen Inc.’s torferson, a treatment for a rare form of amyotrophic lateral sclerosis, or…
Read more Biogen wins accelerated FDA approval for treatment for rare form of ALS